Gestational trophoblastic neoplasm and women living with HIV and/or AIDS

Southern African Journal of HIV Medicine

Field Value
Title Gestational trophoblastic neoplasm and women living with HIV and/or AIDS
Creator Barnardt, Pieter Relling, Martha
Subject Clinical Oncology Gestational Trophoblastic Neoplasm (GTN), HIV/AIDS, Choriocarcinoma, Chemotherapy
Description The 2011 World Health Organization global report on HIV and/or AIDS estimated that sub-Saharan Africa comprised 67% of the global HIV burden, with a current estimate of 5.9 million cases in South Africa. Since the introduction of antiretroviral therapy, there has been an increase in the incidence of non-AIDS-defining cancers. Gestational trophoblastic neoplasm (GTN) is a rare pregnancy-related disorder with an incidence ranging from 0.12–0.7/1000 pregnancies in Western nations. The overall cure rate is about 90%. Response to treatment for GTN is generally favourable; but the sequelae of HIV and/or AIDS, the resultant low CD4 counts, comorbidities, poor performance status and the extent of metastatic disease in patients receiving chemotherapy, compromise the prognosis and survival.
Publisher AOSIS
Date 2015-07-03
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Case Report
Format text/html application/octet-stream text/xml application/pdf
Identifier 10.4102/sajhivmed.v16i1.344
Source Southern African Journal of HIV Medicine; Vol 16, No 1 (2015); 4 pages 2078-6751 1608-9693
Language eng
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
Coverage — — —
Rights Copyright (c) 2015 Pieter Barnardt, Martha Relling